Skip to main content
Fig. 6 | Journal of Translational Medicine

Fig. 6

From: m6A RNA modification and its writer/reader VIRMA/YTHDF3 in testicular germ cell tumors: a role in seminoma phenotype maintenance

Fig. 6

Immunostaining intensity of VIRMA, YTHDF3 and m6A. a m6A vs. VIRMA immunostaining intensity; b VIRMA immunostaining intensity among seminomas vs. non-seminomatous Tumors; c–e VIRMA, YTHDF3 and m6A immunostaining intensity among different tumor subtypes. SE Seminoma; EC embryonal carcinoma, YST pospubertal-type Yolk sac tumor, CH choriocarcinoma, TE postpubertal-type teratoma, NST non-seminomatous tumors

Back to article page